USING COST-EFFECTIVENESS ANALYSIS TO IMPROVE THE EFFICIENCY OF ALLOCATING FUNDS TO CLINICAL-TRIALS

被引:38
作者
DETSKY, AS
机构
[1] Toronto General Hospital, Toronto, Ontario, M5G 2C4, 200 Elizabeth Street
关键词
D O I
10.1002/sim.4780090124
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
This study applied a cost‐effectiveness model to seven randomized trials. The model demonstrates the effect of design choices made in the planning stages of a clinical trial on the costs and benefits derived from conducting the trial. The study focused on one parameter used to calculate sample size: the minimum clinically important difference in event rates between control and experimental therapies. The study shows that the model can be operationalized to these trials. A computerized software package and manual has been developed to simplify the calculations. While there was some variation in the incremental cost‐effectiveness ratios across the seven trials in this study, all ratios may be below the funding threshold. This analytical technique can be used to demonstrate explicitly the resource consequences of the design of randomized trials and perhaps to set funding priorities. Copyright © 1990 John Wiley & Sons, Ltd.
引用
收藏
页码:173 / 184
页数:12
相关论文
共 23 条
  • [1] Detsky A.S., Naglie I.G.
  • [2] Detsky A.S., Using economic analysis to determine the resource consequences of choices made in planning clinical trials, Journal of Chronic Diseases, 38, pp. 753-765, (1985)
  • [3] Weinstein M., Cost‐effectiveness of cancer prevention, Science, 221, pp. 17-23, (1983)
  • [4] Thompson M.S., Decision‐analytic determination of study size: the case of electronic fetal monitoring, Medical Decision Making, 1, pp. 167-179, (1981)
  • [5] Baker S., Heidenberger K., Choosing sample sizes to maximize expected health benefits subject to a constraint on total trial costs, Medical Decision Making, 9, pp. 14-25, (1989)
  • [6] Beck J.R., Kassirer J.P., Pauker S.G., A convenient approximation of life expectancy (the “DEALE”), American Journal of Medicine, 73, pp. 883-896, (1982)
  • [7] L'Abbe K.A., Detsky A.S., O'Rourke K., Meta‐analysis in clinical research, Annals of Internal Medicine, 107, pp. 224-233, (1987)
  • [8] The Coronary Primary Prevention Trial: design and implementation, Journal of Chronic Diseases, 32, pp. 609-631, (1979)
  • [9] The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease, Journal of the American Medical Association, 251, pp. 351-364, (1984)
  • [10] Coronary Artery Surgery Study (CASS): a randomized trial of coronary artery bypass surgery, Circulation, 68, pp. 939-950, (1983)